NEW YORK (GenomeWeb) – Quidel said after the close of the market on Wednesday that the US Food and Drug Administration has cleared the company's AmpliVue Bordetella Assay. 

The assay detects Bordetella pertussis nucleic acids isolated from nasopharyngeal swab specimens from patients suspected of having a respiratory tract infection due to the bacteria, which causes whooping cough. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.